Skip to content

New Feature: Text Message Treatment Updates

New Feature: Text Message Treatment Updates

New to the Arfinn Med portal comes the ability to receive real time updates from patients via text messaging. This new addition will allow physicians to stay up to date on current patient efficacies as well as streamline the data collection process. Through the new text messaging function, physicians are able to send patients automated texts with the intention of collecting data on their medical cannabis treatment outcomes.

How It Works

When creating a new patient case, physicians input the patient’s phone number along with all other relevant information. Once a phone number is entered, a drop-down box will appear offering the physician to choose if the patient has opted in for text message updates. These text message updates will automatically be sent to the patient at a specific date and time with a request to rate their treatment efficacy on a scale of one (Adverse Reaction) to five (Total Resolution of Symptoms). All the patient will then have to do is respond with a number (1 through 5), and the data is collected in their case file.

The Benefit

“We want to ensure that physicians have real-time responses from their patients about their medical cannabis treatment plans,” said James West, founder and CEO of Arfinn Med. “Several states have long durations between required appointments, so physicians need to have tools to track their patients’ progress and create an open dialogue during a treatment period to increase the likelihood that the treatment plan will be further customized for the patient.”

Providing this type of feature will significantly save physicians time when collecting updates from patients. Instead of lengthy office visits or following up via phone call, one text can collect all the information needed. All data received through this text messaging feature is a real time update to help give a full picture of how that specific treatment is affecting each patient. Along with saving both the physician and patient time, this feature is also expected to increase patient retention. With such a hands-on approach, the text messaging feature will encourage patients to keep their physicians updated and refine the treatment plan, if/as needed, to obtain the results they desire.


At Arfinn Med, we are dedicated to helping medical professionals and their patients combat debilitating diseases and conditions with the use of medical marijuana. By relying on actual physician observations regarding patient outcomes, doctors can create reports based on the effectiveness, daily dosage and delivery mode of cannabis treatments specific to various patient demographics. Are you ready to join a nationwide network of medical professionals to learn more about medical marijuana and what it can do for your patients? Join Arfinn Med for FREE today!

Stories you may be interested in

Dr. Sanjay Gupta on medical marijuana: We are in an age of wisdom, but also an age of foolishness

When we released “Weed” in 2013, few people had ever heard of cannabidiol, or CBD. Now, two-thirds of Americans are familiar with the compound, and 1 in 7 have tried it. Most of the country, 93%, are in favor of medical marijuana and hemp-derived CBD itself, which has less than 0.3% THC, has been legalized in every state.It’s…
Read More

After marijuana edibles helped dying Holocaust survivor battle Alzheimer’s, his family’s foundation pushes for more research

A Massachusetts family’s experience giving marijuana edibles to their dying patriarch is set to kick off a desperately needed investigation into how cannabis might treat some of the more troubling symptoms of Alzheimer’s disease, a condition that affects 5.7 million Americans. Read the full story here.
Read More

Cannabis improves symptoms of Crohn’s disease despite having no effect on gut inflammation

In the first study of its kind, cannabis oil has been shown to significantly improve the symptoms of Crohn’s disease and the quality of life of sufferers but, contrary to previous medical thinking, has no effect on gut inflammation. In a randomised, placebo-controlled study, researchers from Israel have shown that cannabis can produce clinical remission…
Read More

REGISTRATION NOW OPEN: Arfinn Med Medical Cannabis Efficacy Portal for Licensed Medical Professionals

Arfinn Med, the first clinician-based medical professional and patient efficacy portal for medical cannabis treatments, is now open for registrations from licensed medical professionals. The free collaborative portal allows medical professionals to register, share, research and communicate HIPAA-compliant benchmark data for medical cannabis treatments. As a free tool for physicians, Arfinn Med offers a new…
Read More

World Cancer Day – Shine a Light on the World

In 2018, it was estimated that 1,735,350 new cancer cases would be diagnosed in the United States and 609,640 individuals would pass from the disease [Cancer.gov]. We cannot sit by and ignore this life altering disease, which is why World Cancer Day, recognized on Feb. 4, is such an important awareness campaign to the Arfinn…
Read More

After 50 Years, U.S. Opens The Door To More Cannabis Crops For Scientists

After more than 50 years, the federal government is lifting a roadblock to cannabis research that scientists and advocates say has hindered rigorous studies of the plant and possible drug development. Since 1968, U.S. researchers have been allowed to use cannabis from only one domestic source: a facility based at the University of Mississippi, through a…
Read More